FANCB

FANCB (originally identified as FAAP95) is an X-linked component of the Fanconi anemia (FA) core complex that acts upstream to promote FANCD2 monoubiquitination during the repair of DNA interstrand crosslinks (ICLs) (PMID:15611632, PMID:21458466). Loss of FANCB abolishes MMC- and crosslink-induced FANCD2 foci formation and reduces RAD51 foci, sister chromatid exchange, and gene targeting, producing crosslinker hypersensitivity and chromosomal instability, while a parallel MUS81-dependent route handles replication-fork repair independently of FANCB (PMID:17903171, PMID:21458466). Biochemical reconstitution establishes that FANCB protein is indispensable for FANCD2 monoubiquitination, and the degree of residual monoubiquitination conferred by FANCB missense variants correlates with clinical severity (PMID:32106311). Beyond canonical ICL repair, FANCB has dedicated germline and stem-cell roles: during male meiosis it localizes to the sex chromosomes in an MDC1/γH2AX-dependent manner, is required for meiotic FANCD2 localization, and shapes sex-chromosome H3K9 methylation (decreasing H3K9me2 and increasing H3K9me3 upon loss), with FANCB-mutant mice showing primordial germ cell defects and spermatogonial failure (PMID:26123487); it also maintains hematopoietic stem cell quiescence and repopulating capacity (PMID:26658157). Truncating loss-of-function FANCB mutations cause X-linked VACTERL-hydrocephalus syndrome in hemizygous males, with carrier females showing skewed X-inactivation (PMID:21910217).

1. 2005 Medium

   Established the molecular identity and pathway position of FANCB by showing the true FANCB protein is FAAP95, a core-complex member acting upstream of FANCD2, resolving prior confusion with BRCA2.

   Evidence Biochemical identification of FAAP95 with epistasis/complementation placing FANCB upstream of FANCD2 monoubiquitination

   PMID:15611632

   Open questions at the time

   • Did not define the biochemical activity FANCB contributes to monoubiquitination
   • Core-complex subunit interactions not mapped at the structural level
2. 2007 High

   Distinguished FANCB's ICL-repair function from a parallel replication-fork pathway, showing FANCB is required for FANCD2 foci but not for SCE, gene targeting, or HU-induced fork repair, which depend on MUS81.

   Evidence FANCB and/or MUS81 knockout in human Nalm-6 cells with FANCD2/RAD51 foci, SCE, gene-targeting, and MMC/CPT/HU survival assays

   PMID:17903171

   Open questions at the time

   • Mechanism by which FANCB selectively channels crosslink versus fork lesions not resolved
3. 2011 High

   Confirmed in a clean mammalian knockout that FANCB is required for FancD2 monoubiquitination/foci and homologous-recombination repair of ICLs.

   Evidence Fancb-knockout mouse ES cells assayed for MMC sensitivity, chromosomal aberrations, SCE, gene targeting, and Rad51/FancD2 foci

   PMID:21458466

   Open questions at the time

   • Did not address tissue-specific or developmental roles in vivo
4. 2011 Medium

   Linked FANCB loss-of-function directly to human disease, defining truncating mutations as the cause of X-linked VACTERL-hydrocephalus syndrome.

   Evidence Clinical/molecular characterization of carriers with chromosome breakage assays and X-inactivation analysis across multiple families

   PMID:21910217

   Open questions at the time

   • No biochemical reconstitution to quantify residual activity of specific variants
   • Genotype-phenotype mechanism not yet established
5. 2015 High

   Revealed a meiotic, epigenetic role for FANCB beyond ICL repair: recruitment to sex chromosomes via MDC1/γH2AX and control of sex-chromosome H3K9 methylation and germ cell maintenance.

   Evidence First X-linked FA (Fancb mutant) mouse with fertility assays, immunofluorescence for FANCB/FANCD2/MDC1/γH2AX/H3K9me2/H3K9me3, and spermatogonial analysis

   PMID:26123487

   Open questions at the time

   • Molecular mechanism linking FANCB to H3K9 methyltransferase/demethylase activity unknown
   • Whether the meiotic role requires FANCD2 monoubiquitination not dissected
6. 2015 High

   Demonstrated a hematopoietic stem cell role, showing FANCB maintains HSC quiescence, progenitor activity, and repopulating capacity under stress.

   Evidence Fancb-/y mouse with HSC flow cytometry, colony-forming and competitive transplantation assays, MMC/5-FU stress models, and RNA-seq

   PMID:26658157

   Open questions at the time

   • Whether HSC defects derive from ICL-repair failure or a distinct FANCB function not separated
7. 2017 Medium

   Used a patient mosaic intragenic duplication (p.A319*) to confirm by complementation that FANCB truncation abolishes FANCD2 ubiquitination and foci while WT rescues.

   Evidence ArrayCGH/PacBio breakpoint mapping and lentiviral complementation of FANCB-null cells with WT/mutant constructs; FANCD2 ubiquitination/foci assays; ddPCR mosaicism

   PMID:29193904

   Open questions at the time

   • Single-lab complementation
   • Functional consequence of mosaicism in patient tissues not quantified
8. 2020 High

   Quantitatively connected FANCB biochemistry to clinical severity, showing residual FANCD2 monoubiquitination activity of missense variants correlates with disease onset and survival.

   Evidence Transcript analysis, genetic complementation in FANCB-null cells, and biochemical reconstitution of FANCD2 monoubiquitination with WT/mutant FANCB across patients

   PMID:32106311

   Open questions at the time

   • Structural basis for how individual residues support the monoubiquitination reaction unresolved

• The biochemical activity FANCB contributes within the core complex and the molecular link between FANCB and sex-chromosome H3K9 methylation remain undefined.
• No structural model of FANCB within the FA core complex
• Mechanism connecting FANCB to histone methylation machinery not identified
• Whether HSC and germline roles are separable from ICL repair not resolved